From the Department of Radiology (K.Sun, W.C., Y.Z., K.C., F.Y.), Comprehensive Breast Health Center (X.C., K.Shen), and Department of Pathology (X.F.), Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, No. 197 Ruijin Er Road, Shanghai 200025, China; and Siemens MRI Center, Siemens Shenzhen Magnetic Resonance Ltd, Shenzhen, P.R. China (C.F., X.Y.).
Radiology. 2015 Oct;277(1):46-55. doi: 10.1148/radiol.15141625. Epub 2015 May 4.
To assess diagnostic accuracy with diffusion kurtosis imaging (DKI) in patients with breast lesions and to evaluate the potential association between DKI-derived parameters and breast cancer clinical-pathologic factors.
Institutional review board approval and written informed consent were obtained. Data from 97 patients (mean age ± standard deviation, 45.7 years ± 13.1; range, 19-70 years) with 98 lesions (57 malignant and 41 benign) who were treated between January 2014 and April 2014 were retrospectively analyzed. DKI (with b values of 0-2800 sec/mm(2)) and conventional diffusion-weighted imaging data were acquired. Kurtosis and diffusion coefficients from DKI and apparent diffusion coefficients from diffusion-weighted imaging were measured by two radiologists. Student t test, Wilcoxon signed-rank test, Jonckheere-Terpstra test, receiver operating characteristic curves, and Spearman correlation were used for statistical analysis.
Kurtosis coefficients were significantly higher in the malignant lesions than in the benign lesions (1.05 ± 0.22 vs 0.65 ± 0.11, respectively; P < .0001). Diffusivity and apparent diffusion coefficients in the malignant lesions were significantly lower than those in the benign lesions (1.13 ± 0.27 vs 1.97 ± 0.33 and 1.02 ± 0.18 vs 1.48 ± 0.33, respectively; P < .0001). Significantly higher specificity for differentiation of malignant from benign lesions was shown with the use of kurtosis and diffusivity coefficients than with the use of apparent diffusion coefficients (83% [34 of 41] and 83% [34 of 41] vs 76% [31 of 41], respectively; P < .0001) with equal sensitivity (95% [54 of 57]). In patients with invasive breast cancer, kurtosis was positively correlated with tumor histologic grade (r = 0.75) and expression of the Ki-67 protein (r = 0.55). Diffusivity was negatively correlated with tumor histologic grades (r = -0.44) and Ki-67 expression (r = -0.46).
DKI showed higher specificity than did conventional diffusion-weighted imaging for assessment of benign and malignant breast lesions. Patients with grade 3 breast cancer or tumors with high expression of Ki-67 were associated with higher kurtosis and lower diffusivity coefficients; however, this association must be confirmed in prospective studies.
评估扩散峰度成像(DKI)在乳腺病变患者中的诊断准确性,并评估 DKI 衍生参数与乳腺癌临床病理因素之间的潜在关联。
本研究获得了机构审查委员会的批准和书面知情同意。回顾性分析了 2014 年 1 月至 2014 年 4 月期间接受治疗的 97 例(平均年龄±标准差,45.7 岁±13.1;范围 19-70 岁)98 个病灶(57 个恶性病灶和 41 个良性病灶)患者的数据。采集 DKI(b 值为 0-2800 sec/mm²)和常规扩散加权成像数据。两位放射科医生测量了 DKI 的峰度和扩散系数以及扩散加权成像的表观扩散系数。采用学生 t 检验、Wilcoxon 符号秩检验、Jonckheere-Terpstra 检验、受试者工作特征曲线和 Spearman 相关分析进行统计学分析。
恶性病灶的峰度系数明显高于良性病灶(分别为 1.05±0.22 和 0.65±0.11;P<0.0001)。恶性病灶的扩散率和表观扩散系数明显低于良性病灶(分别为 1.13±0.27 和 1.97±0.33、1.02±0.18 和 1.48±0.33;P<0.0001)。与表观扩散系数相比,使用峰度和扩散系数区分良恶性病变的特异性更高(分别为 83%[34/41]和 83%[34/41] vs 76%[31/41];P<0.0001),且敏感性相同(95%[54/57])。在浸润性乳腺癌患者中,峰度与肿瘤组织学分级(r=0.75)和 Ki-67 蛋白表达(r=0.55)呈正相关。扩散率与肿瘤组织学分级(r=-0.44)和 Ki-67 表达(r=-0.46)呈负相关。
与常规扩散加权成像相比,DKI 对评估乳腺良恶性病变具有更高的特异性。3 级乳腺癌或 Ki-67 高表达的肿瘤与更高的峰度和更低的扩散系数相关;然而,这种相关性需要在前瞻性研究中得到证实。